1Steven B.Knight,Dominique Delbeke,JamesR.Sewart et al.Evaluation of Pulmonary Lesions with FDG- PET: Comparison of Findings in With and Without a History of Prior Malignancy.Chest,1996,109:982～988
2Naresh A.Dewan,Naresh C.Gupta,Lisa S.Redpenning et al.Diagnostic Efficacy of PET-FDG imaging in Solitary Pulmonary Nodules: Potential Role in Evaluation and Management.Chest,1993,104:997～1002
3Naresh Gupta,Harmindar Gill,Geoffrey Graeber et al.Dynamic Positron Emission Tomography With F-18 Fluorodeoxyglucose Imaging in Differentiation of Benogn From Malignant Lung/Mediastinal Lesions.Chest,1998,114: 1105 ～ 1111
4G Lakinga,P Pricea B.18-Fluorodexyglucose positron emission tomography (FDG-PET)and the staging of early lung cancer.Thorax,2001,56(supp12): 38～44
5A Gulmann,M Storck,J Kotzerke et al.Lymph node staging in non-small cell lung cancer: evaluation by [18F] FDG positron emisson tomography(PET).Thorax,1997,52: 438 ～ 441
6V.J.Lowe.Respir Care Clin:Positron emission tomography scanning in lung cancer.2003,9:119 ～ 136
7Patz J ,V J.Lowe,C.Goodman et al.Thoracic Nodal Staging With PET Imaging With FDG in Patients With Bronchogenic Carcinoma.Chest,1995,108:1617～1621
8T Bury,P Paulus,A Dowlati et al.Evaluation of pleural disease with FDG-imaging: preliminary report.Thorax,1997,52:187 ～189
9G J Herder,H van Tinteren,E F Comans et al.Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18 Ffluorodeoxyglucosc (FDG) positron emission tomography (PET)in suspected lung cancer.Thorax,2003,58:47～51
10Angelo Carretta,Claudio Landoni,Giulio Melloni et al.18-FDG Positron emission tomography in the evaluation of malignant pleural disease-a pilot study.Eur J cardiothorac Surg.2000,17:377～383
4La Rosa De GR, Jacobson KL, Rolston KV. Mycobacterium tuberculosis at a comprejensive cancer cetre:Active disease in patients with underlying malignancy during 1990 -2000. Clin Microblol Infect, 2004, 10:749.
